AU591680B2 - Preventive drugs for elastosis - Google Patents

Preventive drugs for elastosis

Info

Publication number
AU591680B2
AU591680B2 AU58897/86A AU5889786A AU591680B2 AU 591680 B2 AU591680 B2 AU 591680B2 AU 58897/86 A AU58897/86 A AU 58897/86A AU 5889786 A AU5889786 A AU 5889786A AU 591680 B2 AU591680 B2 AU 591680B2
Authority
AU
Australia
Prior art keywords
drugs
elastosis
kojic acid
effective
preventive drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU58897/86A
Other languages
English (en)
Other versions
AU5889786A (en
Inventor
Shinkichi Hatae
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sansho Pharmaceutical Co Ltd
Original Assignee
Sansho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sansho Pharmaceutical Co Ltd filed Critical Sansho Pharmaceutical Co Ltd
Publication of AU5889786A publication Critical patent/AU5889786A/en
Application granted granted Critical
Publication of AU591680B2 publication Critical patent/AU591680B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Electroluminescent Light Sources (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU58897/86A 1985-07-02 1986-06-16 Preventive drugs for elastosis Expired AU591680B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP60146029A JPH0613448B2 (ja) 1985-07-02 1985-07-02 皮膚弾力線維症予防剤
JP60-146029 1985-07-02

Publications (2)

Publication Number Publication Date
AU5889786A AU5889786A (en) 1987-01-08
AU591680B2 true AU591680B2 (en) 1989-12-14

Family

ID=15398494

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58897/86A Expired AU591680B2 (en) 1985-07-02 1986-06-16 Preventive drugs for elastosis

Country Status (17)

Country Link
US (1) US4891361A (cg-RX-API-DMAC7.html)
EP (1) EP0207499B1 (cg-RX-API-DMAC7.html)
JP (1) JPH0613448B2 (cg-RX-API-DMAC7.html)
KR (1) KR890004556B1 (cg-RX-API-DMAC7.html)
AT (1) ATE75396T1 (cg-RX-API-DMAC7.html)
AU (1) AU591680B2 (cg-RX-API-DMAC7.html)
CA (1) CA1282332C (cg-RX-API-DMAC7.html)
DE (1) DE3685060D1 (cg-RX-API-DMAC7.html)
DK (1) DK166429B1 (cg-RX-API-DMAC7.html)
FI (1) FI862806A0 (cg-RX-API-DMAC7.html)
GR (1) GR861671B (cg-RX-API-DMAC7.html)
HK (1) HK51594A (cg-RX-API-DMAC7.html)
IE (1) IE59082B1 (cg-RX-API-DMAC7.html)
IN (1) IN165985B (cg-RX-API-DMAC7.html)
PH (1) PH22349A (cg-RX-API-DMAC7.html)
PT (1) PT82889B (cg-RX-API-DMAC7.html)
ZA (1) ZA864166B (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2809429B2 (ja) * 1989-05-26 1998-10-08 湧永製薬株式会社 制ガン剤ならびに制ガン剤として有用な新規複素環化合物またはそれらの塩
JPH04298437A (ja) * 1991-03-26 1992-10-22 Fuji Photo Film Co Ltd 画像形成装置
US5296472A (en) * 1991-12-05 1994-03-22 Vyrex Corporation Methods for delipidation of skin and cerumen removal
JP3566739B2 (ja) * 1993-09-30 2004-09-15 三省製薬株式会社 皮膚外用剤の安定化方法
US5874463A (en) 1994-10-24 1999-02-23 Ancira; Margaret Hydroxy-kojic acid skin peel
US6596263B1 (en) * 1995-07-14 2003-07-22 Stc English Ideas, Inc. Cyclodextrin compositions
GB2307176A (en) * 1995-11-15 1997-05-21 Todd Selwyn Everest Anti-inflammatory clathrating agents for topical use
KR100471372B1 (ko) * 2001-12-04 2005-03-08 주식회사 태평양 피부 탄력 향상용 화장료 조성물
US20040126339A1 (en) * 2002-12-31 2004-07-01 Roszell James A. Sunscreen composition and methods for manufacturing and using a sunscreen composition
US20080070982A1 (en) * 2006-09-15 2008-03-20 Graham Timmins System and methods of melanoma prevention

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS533538A (en) * 1976-06-28 1978-01-13 Sansho Seiyaku Kk Skin bleach cosmetics
JPS55157509A (en) * 1979-05-24 1980-12-08 Sansho Seiyaku Kk Ultraviolet ray intercepting agent safe to skin
JPS61109705A (ja) * 1984-11-01 1986-05-28 Sansho Seiyaku Kk 色白化粧料

Also Published As

Publication number Publication date
FI862806A0 (fi) 1986-07-01
HK51594A (en) 1994-05-27
DK313786D0 (da) 1986-07-01
PT82889A (en) 1986-08-01
DK313786A (da) 1987-01-03
GR861671B (en) 1986-10-30
EP0207499A2 (en) 1987-01-07
JPH0613448B2 (ja) 1994-02-23
ZA864166B (en) 1987-02-25
DE3685060D1 (de) 1992-06-04
IE59082B1 (en) 1994-01-12
US4891361A (en) 1990-01-02
PT82889B (pt) 1988-05-27
KR870000931A (ko) 1987-03-10
EP0207499B1 (en) 1992-04-29
IE861481L (en) 1987-01-02
IN165985B (cg-RX-API-DMAC7.html) 1990-02-17
CA1282332C (en) 1991-04-02
JPS625909A (ja) 1987-01-12
AU5889786A (en) 1987-01-08
ATE75396T1 (de) 1992-05-15
KR890004556B1 (ko) 1989-11-15
EP0207499A3 (en) 1989-04-26
PH22349A (en) 1988-08-12
DK166429B1 (da) 1993-05-24

Similar Documents

Publication Publication Date Title
US5523077A (en) Composition and method for whitening skin
GB1467673A (en) Method of protecting human skin from actinic radiation
JPS6483010A (en) Melanization inhibitory drug for external use
EG18334A (en) Pyrozoline compounds and their use as pesticides
ATE269089T1 (de) Verwendung von vitamin d derivaten zur verstärkung der wirkung von zytotoxischen stoffen
FR2784294B1 (fr) Composition cosmetique et/ou dermatologique renfermant au moins un extrait de murier, au moins un extrait de scutellaire et au moins un derive d'acide salicylique
CA2068028A1 (en) Liposoluble antioxidant mixture
AU591680B2 (en) Preventive drugs for elastosis
MX9307509A (es) Metodo y preparacion farmaceutica para reducir la actividad de las celulas.
CA2015838A1 (en) Method of topically treating acne vulgaris
GEP19991872B (en) Novel Taxoids, Preparations Thereof, and Pharmaceutical Compositions Containing Same
ATE258916T1 (de) Ungesättigte hydroximsäurederivate als parp inhibitoren
KR950014093A (ko) 코지산 유도체
ES8800217A1 (es) Procedimiento para la preparacion de acidos 4-(isoxazolil)-tiazol-2-oxamicos y sus derivados
ATE100670T1 (de) Pflanzenfungizide mittel enthaltend als wirstoffe salze der pyrophosphorigen saeure und ihre anwendung.
AU585279B2 (en) Pesticidal biphenylyloxy and biphenylylalkoxy aryl acyl urea compounds
IE43994L (en) Diphenylmethanes.
JP2000191504A (ja) 肌を白くする化粧料組成物
Sweetman et al. The effect of 2‐phenylisatogen on oxidative phosphorylation in rat liver mitochondria
JPS6483007A (en) Cosmetic
GB1503418A (en) Rodenticide
DE3665403D1 (en) Pharmaceutical composition for topical application
IT1233426B (it) Composizioni farmaceutiche per uso orale ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo, e procedimento per prepararle
GB1475426A (cg-RX-API-DMAC7.html)
SU1139143A1 (ru) Гидрохлорид 3-(2-диэтиламиноэтилтио)-9-метил-1,2,4-триазино/6,5-в/ индола, обладающий противогипоксической активностью